Search details
1.
Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS).
Dysphagia
; 38(4): 1087-1095, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36289072
2.
Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!
Vnitr Lek
; 69(5): 294-298, 2023.
Article
in English
| MEDLINE | ID: mdl-37827827
3.
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
BMC Neurol
; 22(1): 270, 2022 Jul 19.
Article
in English
| MEDLINE | ID: mdl-35854235
4.
Effect of Tai-chi on balance, mood, cognition, and quality of life in women with multiple sclerosis: A one-year prospective study.
Explore (NY)
; 20(2): 188-195, 2024.
Article
in English
| MEDLINE | ID: mdl-37596158
5.
Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.
Front Immunol
; 14: 1149629, 2023.
Article
in English
| MEDLINE | ID: mdl-37398654
6.
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 2023 Apr 28.
Article
in English
| MEDLINE | ID: mdl-37114703
7.
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection.
Mult Scler Relat Disord
; 65: 104014, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35803085
8.
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Mult Scler Relat Disord
; 54: 103104, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34216998
9.
Corrigendum to 'To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection'[Multiple sclerosis and related disorders vol. 65 (2022) 104014].
Mult Scler Relat Disord
; 70: 104549, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36796224
Results
1 -
9
de 9
1
Next >
>>